|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs 显示文摘 | BU HZ GUKASYAN H J GOULET L | 2007 | Curr Drug Metab2007，8，2： | 1 |
| 2 | Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs 显示文摘 | Bu HZ Gukasyan H J Goulet L | 2007 | Curr Drug Metab2007，8，： | 1 |
| 3 | Development and validation of a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of ribavirin in human plasma and serum 显示文摘 | Shou WZ Bu HZ Addison T | 2002 | J Pharm Biomed Anal2002，29，12： | 1 |
| 4 | Pharmaeokinetics, distribution, and metabolism of sunitinib in rats, monkeys, and humans 显示文摘 | Speed B Bu HZ Pool WF | 2012 | Drug Metab Dispos2012，40，： | 1 |
| 5 | Development and valida- tion of a liquid chromatography/tandem mass spectrometry (LC MA-MA) method for the determination of ribavirin in hu- man plasma and serum 显示文摘 | Shou WZ Bu HZ Addison T | 2002 | J Pharm Biomed Anal2002，29，12： | 1 |
| 6 | Human in vitro glutathionyl and protein adducts of carbamazepine - 10,11 - epoxide, a stable and pharmacologically active metabolite of carbamazepine 显示文摘 | Bu HZ Kang P Deese All | 2005 | Drug Metab Dispos2005，33，： | 1 |
| 7 | Development and vali- dation of a liquid chromatography/tandem mass spectrom- etry (LC/MS/MS) method for the determination of ribavi- fin in human plasma and serum显示文摘 | Shou WZ Bu HZ Addison T | 2002 | JPharm BiornedAnal2002，29，12： | 1 |
| 8 | Pharmacokinetics, Distribution, and Metabolism of E14C~ Sunitinib in Rats, Monkeys, and Humans 显示文摘 | Speed B Bu HZ Pool WF | 2012 | Drug Metab Dispos2012，40，3： | 1 |
| 9 | Ocular disposition,pharmacokinetics,efficacy and safety of nanoparticleformulated ophthalmic drugs显示文摘 | Bu HZ Gukasyan HJ Goulet L | 2007 | Curr Drug Metab2007，8，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员